安图生物：国内最大体外诊断产业园拔节生长（开局就是奋斗 起步就要奋进）

Core Insights - The construction of the largest in vitro diagnostic industry park in China is accelerating in Zhengzhou, with a total investment of approximately 6 billion yuan and a total area of 720,000 square meters [1][2] - Antu Bio is focusing on R&D and manufacturing of in vitro diagnostic reagents and instruments, with products covering immunology, microbiology, and biochemistry, and has established a strong presence in over 2,600 tertiary hospitals across China [1][2] Group 1 - The Antu Bio industry park is a key provincial project, with all main buildings completed and interior renovations underway, expected to be fully operational after the completion of the third phase [1] - The park will include a research and development center, a modern manufacturing center, a large cold storage facility, and the first medical testing museum in China [1] - Antu Bio has invested over 3 billion yuan in R&D during the 14th Five-Year Plan period, with R&D expenses consistently exceeding 14% of total revenue, positioning the company among the top tier in the industry [2] Group 2 - The company has a workforce of over 1,900 R&D personnel, making it one of the most research-intensive firms in the industry [2] - Antu Bio aims to enhance its product offerings in precision diagnostics and expand into emerging fields such as immunology and allergens, while also accelerating its international expansion [3] - Zhengzhou city has planned 523 key projects for the year, with a total investment of approximately 743.89 billion yuan, emphasizing the importance of high-quality projects for economic development [3]